MAKESURE PHARMA PRIVATE LIMITED
MAKESURE PHARMA PRIVATE LIMITED is a DELHI based PRIVATE LIMITED company, Registered at dated 17-APR-2013 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of MAKESURE PHARMA PRIVATE LIMITED is U24100DL2013PTC250883 and registration number is 250883.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies DELHI India. Authorized share capital of MAKESURE PHARMA PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on 2014-03-31 and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on 2014-03-31.
MAKESURE PHARMA PRIVATE LIMITED has 2 directors JEGAM ABBAS, TANJEEM ARSHI,
The registered Email address of MAKESURE PHARMA PRIVATE LIMITED is alwayscarepharma@gmail.com and its registered address is J - 3/32 B, KH NO 30, F. FLOOR F/S, KHIRKI EXT NEW DELHI DELHI INDIA 110017 DELHI DELHI india 110017.
The current status of MAKESURE PHARMA PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
MAKESURE PHARMA PRIVATE LIMITED
DELHI
ACTIVE
METALS, CHEMICALS and PRODUCTS THEREOF MANUFACTURING
U24100DL2013PTC250883
17 APR 2013
COMPANY LIMITED BY SHARES
NON-GOVT COMPANY
PRIVATE
100000
100000
2014-03-31
2014-03-31
CONTACT DETAILS
110017
INDIA
J - 3/32 B, KH NO 30, F. FLOOR F/S, KHIRKI EXT NEW DELHI DELHI INDIA 110017
alwayscarepharma@gmail.com
DIRECTOR DETAILS
| DIN | Director Name | Designation | Appointment Date |
|---|---|---|---|
| 06518089 | JEGAM ABBAS | Director | 17/04/2013 |
| 06518114 | TANJEEM ARSHI | Director | 17/04/2013 |
Details Updated by Companies
Quick Links
- All Registered company of DELHI
- Company Registered in DELHI
- All Registered company of SOUTH DELHI in DELHI
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.